7-((1R,2R,3R)-3-Hydroxy-2-((S,1E,5E)-3-hydroxyocta-1,5-dien-1-yl)-5-oxocyclopentyl)heptanoic acid

Catalog No. :
ACDVOU852
CAS No. :
119008-22-9
Molecular Formula :
C20H32O5
Molecular Weight :
352.47

IUPAC Name:7-((1R,2R,3R)-3-hydroxy-2-((S,1E,5E)-3-hydroxyocta-1,5-dien-1-yl)-5-oxocyclopentyl)heptanoic acid

7-((1R,2R,3R)-3-Hydroxy-2-((S,1E,5E)-3-hydroxyocta-1,5-dien-1-yl)-5-oxocyclopentyl)heptanoic acid structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g95%$1522.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name7-((1R,2R,3R)-3-Hydroxy-2-((S,1E,5E)-3-hydroxyocta-1,5-dien-1-yl)-5-oxocyclopentyl)heptanoic acid
IUPAC Name7-((1R,2R,3R)-3-hydroxy-2-((S,1E,5E)-3-hydroxyocta-1,5-dien-1-yl)-5-oxocyclopentyl)heptanoic acid
Molecular FormulaC20H32O5
Molecular Weight352.47
SMILESO=C(O)CCCCCC[C@@H]1[C@@H](/C=C/[C@@H](O)C/C=C/CC)[C@H](O)CC1=O
InChI KeyOFPLGKUICBQJOS-NFRSEMAFSA-N
SynonymDELTA17-PROSTAGLANDIN E1;9-OXO-11ALPHA,15S-DIHYDROXY-PROSTA-13E,17Z-DIEN-1-OIC ACID;5,6-DIHYDRO PGE3;9-Oxo-11alpha,15s-dihydroxy-prosta-13E,17Z-dien-oic acid;7-((1R,2R,3R)-3-Hydroxy-2-((S,1E,5E)-3-hydroxyocta-1,5-dien-1-yl)-5-oxocyclopentyl)heptanoic acid;7-((1R,2R,3R)-3-Hydroxy-2-((S,1E,5E)-3-hydroxyocta-1,5-dien-1-yl)-5-oxocyclopentyl)heptanoic a;Prosta-13,17-dien-1-oic acid, 11,15-dihydroxy-9-oxo-, (11α,13E,15S)- (9CI)
CAS No.119008-22-9

Synthetic Route by SureRoute

1. ACDVOU852 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACDVOU852 route product structure diagram
    ACDVOU852119008-22-9
Inquiry

2. ACDVOU852 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACDVOU852 route product structure diagram
    ACDVOU852119008-22-9
Inquiry

Comments (0)